# Induced pluripotent stem cells carrying novel APTX mutations presented defective neural differentiation with the accumulation of DNA single-strand breaks

**Authors:** Zirui Chen, Yihua Huang, Zhirong Yuan, Kaibiao Xu, Yuqing Guan, Luqin Wang, Yawei Jiang, Weiling Deng, Yue Pan, Jing Liu, Yafang Hu

PMC · DOI: 10.1038/s41420-025-02723-2 · 2025-10-24

## TL;DR

This study uses stem cells with APTX mutations to show how these mutations impair neural development and cause DNA damage in a rare neurological disorder.

## Contribution

The study introduces a novel iPSC model with APTX mutations to explore the pathogenesis of AOA1 and reveals DNA repair defects during neural differentiation.

## Key findings

- APTX-mutant iPSCs show impaired differentiation into neural progenitor cells and neurons.
- Accumulation of DNA single-strand breaks and increased cleaved PARP-1 is observed in mutant cells.
- Reduced APE1 expression is linked to the base excision repair pathway during neural differentiation.

## Abstract

Ataxia with oculomotor apraxia type 1 (AOA1) is a rare, autosomal recessive, early-onset, progressive cerebellar ataxia caused by mutations in the APTX gene, which encodes aprataxin, a DNA-adenylate hydrolase involved in DNA damage repair. The pathogenesis of AOA1 remains unclear. The purpose of this study was to investigate the pathogenesis of a novel mutation, p.H201P/H201R, carried by our AOA1 patient and the mechanism of AOA1 in an induced pluripotent stem cells (iPSCs) model. We edited iPSCs derived from a healthy individual to carry the APTX homozygous mutation p.H201P (H201P-iPSCs) or p.H201R (H201R-iPSCs) via CRISPR/Cas9. We found that aprataxin expression was absent in both H201P- and H201R-iPSCs. The capacity of these APTX-mutant iPSCs to differentiate into neural progenitor cells (NPCs) and mature neurons was diminished. We observed an increase in DNA single-strand breaks (SSB) via a comet assay and poly(ADP-ribose) staining, and an increase in the ratio of cleaved PARP-1/total PARP-1 in APTX-mutant NPCs and early immature neurons (EiNs), in addition of a heightened sensitivity to tert-butyl hydroperoxide in APTX-mutant EiNs. Moreover, a decrease of APE1 expression was observed in APTX-mutant NPCs and H201R-EiNs during neural differentiation. Our study established a practical iPSCs model to investigate AOA1 disease. We found that mutant aprataxin leads to defective neural differentiation, accompanied by the accumulation of DNA SSBs with increased cleaved PARP-1 and reduced APE1 expression of the base excision repair pathway.

## Linked entities

- **Genes:** APTX (aprataxin) [NCBI Gene 54840]
- **Proteins:** PNKP (Polynucleotide kinase 3'-phosphatase), PARP1 (poly(ADP-ribose) polymerase 1), APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1)
- **Chemicals:** tert-butyl hydroperoxide (PubChem CID 6410)
- **Diseases:** AOA1 (MONDO:0008842)

## Full-text entities

- **Genes:** PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, APTX (aprataxin) [NCBI Gene 54840] {aka AOA, AOA1, AXA1, EAOH, EOAHA, FHA-HIT}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}
- **Diseases:** AOA1 (MESH:C538013), progressive cerebellar ataxia (MESH:D002524)
- **Chemicals:** poly(ADP-ribose) (MESH:D011064), tert-butyl hydroperoxide (MESH:D020122)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** H201P

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12552585/full.md

---
Source: https://tomesphere.com/paper/PMC12552585